Drug intelligence / Profile preview

longikaurin a

Development stage
Preclinical
Lead developer
Sun Yat-sen University
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Longikaurin A is a natural ent-kaurane diterpenoid isolated from the medicinal plant *Isodon ternifolius*. It exhibits potent anti-cancer properties, specifically demonstrated in models of hepatocellular carcinoma (HCC). The compound's mechanism of action involves inducing G2/M phase cell cycle arrest by downregulating the E3 ubiquitin ligase S-phase kinase-associated protein 2 (Skp2), which subsequently leads to the stabilization and increased expression of the cyclin-dependent kinase inhibitor p21. Additionally, Longikaurin A triggers apoptosis through the accumulation of reactive oxygen species (ROS), which activates the JNK/c-Jun signaling pathway. Preclinical studies in SMMC-7721 xenograft models have shown significant tumor suppression with minimal organ-related toxicity, positioning it as a promising lead compound for the development of targeted liver cancer therapies.

Other names
Longikaurin A
02

Targets

JNK (Mitogen-activated protein kinase kinase kinase family)JUN (Transcription factor Jun)SKP2

Beyond the preview

Go deeper on longikaurin a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on longikaurin a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call